96
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Deception and Manipulation: The Arms of Leishmania, a Successful Parasite

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Leishmania spp. are intracellular parasitic protozoa responsible for a group of neglected tropical diseases, endemic in 98 countries around the world, called leishmaniasis. These parasites have a complex digenetic life cycle requiring a susceptible vertebrate host and a permissive insect vector, which allow their transmission. The clinical manifestations associated with leishmaniasis depend on complex interactions between the parasite and the host immune system. Consequently, leishmaniasis can be manifested as a self-healing cutaneous affliction or a visceral pathology, being the last one fatal in 85–90% of untreated cases. As a result of a long host–parasite co-evolutionary process, Leishmania spp. developed different immunomodulatory strategies that are essential for the establishment of infection. Only through deception and manipulation of the immune system, Leishmania spp. can complete its life cycle and survive. The understanding of the mechanisms associated with immune evasion and disease progression is essential for the development of novel therapies and vaccine approaches. Here, we revise how the parasite manipulates cell death and immune responses to survive and thrive in the shadow of the immune system.

          Related collections

          Most cited references225

          • Record: found
          • Abstract: found
          • Article: not found

          CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

          The long-term persistence of pathogens in a host that is also able to maintain strong resistance to reinfection, referred to as concomitant immunity, is a hallmark of certain infectious diseases, including tuberculosis and leishmaniasis. The ability of pathogens to establish latency in immune individuals often has severe consequences for disease reactivation. Here we show that the persistence of Leishmania major in the skin after healing in resistant C57BL/6 mice is controlled by an endogenous population of CD4+CD25+ regulatory T cells. These cells constitute 5-10% of peripheral CD4+ T cells in naive mice and humans, and suppress several potentially pathogenic responses in vivo, particularly T-cell responses directed against self-antigens. During infection by L. major, CD4+CD25+ T cells accumulate in the dermis, where they suppress-by both interleukin-10-dependent and interleukin-10-independent mechanisms-the ability of CD4+CD25- effector T cells to eliminate the parasite from the site. The sterilizing immunity achieved in mice with impaired IL-10 activity is followed by the loss of immunity to reinfection, indicating that the equilibrium established between effector and regulatory T cells in sites of chronic infection might reflect both parasite and host survival strategies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Leishmaniasis: complexity at the host-pathogen interface.

            Leishmania is a genus of protozoan parasites that are transmitted by the bite of phlebotomine sandflies and give rise to a range of diseases (collectively known as leishmaniases) that affect over 150 million people worldwide. Cellular immune mechanisms have a major role in the control of infections with all Leishmania spp. However, as discussed in this Review, recent evidence suggests that each host-pathogen combination evokes different solutions to the problems of parasite establishment, survival and persistence. Understanding the extent of this diversity will be increasingly important in ensuring the development of broadly applicable vaccines, drugs and immunotherapeutic interventions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies

              A thorough understanding of the transmission mechanism of any infectious agent is crucial to implementing an effective intervention strategy. Here, our current understanding of the mechanisms that Leishmania parasites use to ensure their transmission from sand fly vectors by bite is reviewed. The most important mechanism is the creation of a “blocked fly” resulting from the secretion of promastigote secretory gel (PSG) by the parasites in the anterior midgut. This forces the sand fly to regurgitate PSG before it can bloodfeed, thereby depositing both PSG and infective metacyclic promastigotes in the skin of a mammalian host. Other possible factors in transmission are considered: damage to the stomodeal valve; occurrence of parasites in the salivary glands; and excretion of parasites from the anus of infected sand flies. Differences in the transmission mechanisms employed by parasites in the three subgenera, Leishmania, Viannia and Sauroleishmania are also addressed.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/175463
                URI : http://frontiersin.org/people/u/175533
                URI : http://frontiersin.org/people/u/186590
                URI : http://frontiersin.org/people/u/186288
                URI : http://frontiersin.org/people/u/175460
                URI : http://frontiersin.org/people/u/175289
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                20 October 2014
                2014
                : 5
                : 480
                Affiliations
                [1] 1Parasite Disease Group, Institute for Molecular and Cell Biology (IBMC), University of Porto , Porto, Portugal
                [2] 2Department of Biological Sciences, Faculty of Pharmacy, University of Porto , Porto, Portugal
                Author notes

                Edited by: Abhay Satoskar, The Ohio State University, USA

                Reviewed by: Hira Nakhasi, US Food and Drug Administration, USA; Diego A. Vargas-Inchaustegui, National Cancer Institute, USA

                *Correspondence: Anabela Cordeiro da Silva, Parasite Disease Group, Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua do Campo Alegre 823, Porto 4150-180, Portugal e-mail: cordeiro@ 123456ibmc.up.pt

                This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology.

                Article
                10.3389/fimmu.2014.00480
                4202772
                25368612
                9243b5d1-8c7d-4888-b9f6-02d416cd5450
                Copyright © 2014 Cecílio, Pérez-Cabezas, Santarém, Maciel, Rodrigues and Cordeiro da Silva.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 28 July 2014
                : 19 September 2014
                Page count
                Figures: 2, Tables: 3, Equations: 0, References: 249, Pages: 16, Words: 15400
                Categories
                Immunology
                Review Article

                Immunology
                leishmania,immunomodulation,apoptosis,innate immunity,acquired immunity
                Immunology
                leishmania, immunomodulation, apoptosis, innate immunity, acquired immunity

                Comments

                Comment on this article